Acrylic Acid Ethyl Ester

Acrylic Acid Ethyl Ester

SCHEMBL4496165

C=C(C)C(=O)OC.C=C(C)C(=O)OCCO.C=CC(=O)OCC

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 10/20 0.51
THRB P10828 2/20 0.46
ALDH1A1 P00352 7/20 0.44
HPGD P15428 1/20 0.40
TP53 P04637 3/20 0.36
HIF1A Q16665 3/20 0.36
CYP3A4 P08684 2/20 0.36
HSD17B10 Q99714 1/20 0.36
NPSR1 Q6W5P4 1/20 0.34
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
KDM4E B2RXH2 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid Ethyl Ester SCHEMBL11307130 0.96 TSHR (0.47) TSHRTHRBALDH1A1HPGDTP53
Acrylic Acid Ethyl Ester SCHEMBL6376428 0.94 TSHR (0.51) TSHRTHRBALDH1A1HPGDTP53
Acrylic Acid Ethyl Ester SCHEMBL5072675 0.94 TSHR (0.58) TSHRTHRBALDH1A1HPGDTP53
Acrylic Acid Ethyl Ester SCHEMBL8156383 0.90 TSHR (0.53) TSHRTHRBALDH1A1HPGDTP53
Acrylic Acid Methyl Ester SCHEMBL28016867 0.89 TSHR (0.52) TSHRTHRBALDH1A1HPGDTP53
Acrylic Acid Ethyl Ester SCHEMBL28826959 0.89 TSHR (0.61) TSHRTHRBALDH1A1HPGDTP53
Acrylic Acid Ethyl Ester SCHEMBL2370487 0.89 ALDH1A1 (0.52) TSHRTHRBALDH1A1HPGDTP53
SCHEMBL2942280 0.89 TSHR (0.66) TSHRTHRBALDH1A1HPGDTP53
Acrylic Acid Ethyl Ester SCHEMBL5959889 0.89 ALDH1A1 (0.56) TSHRTHRBALDH1A1HPGDTP53
Acrylic Acid Ethyl Ester SCHEMBL146757 0.89 ALDH1A1 (0.56) TSHRTHRBALDH1A1HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020246463-A1 WET COATING AGENT FOR FINE PARTICLES 日本曹達株式会社 2020-12-10 WO disclosed
US-20160095820-A1 METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS UNIV TEXAS (US) 2016-04-07 US disclosed
US-9155703-B2 Method and process for the production of multi-coated recognitive and releasing systems BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2015-10-13 US disclosed
US-8821899-B2 Method and process for the production of multi-coated recognitive and releasing systems BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-09-02 US disclosed
US-8771713-B2 Method and process for the production of multi-coated recognitive and releasing systems BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-07-08 US disclosed
US-20090232857-A1 METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2009-09-17 US disclosed
US-20090232858-A1 METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2009-09-17 US disclosed
US-20080275057-A1 Compounds with anti-cancer activity CANBAS CO., LTD. (JP) 2008-11-06 US disclosed
WO-2008112826-A1 METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2008-09-18 WO disclosed
US-20080226684-A1 METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2008-09-18 US disclosed
EP-0562839-B1 Multi-layer material for colour hologram and process for producing a colour hologram NIPPON PAINT CO LTD (JP) 1997-03-05 EP disclosed
EP-0562839-A1 Multi-layer material for colour hologram and process for producing a colour hologram NIPPON PAINT CO., LTD. (JP) 1993-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275057-A1 Compounds with anti-cancer activity CDKN1A, CDC25C, DDB1 TSHR 4383/4885THRB 4741/4885ALDH1A1 788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.